scholarly journals Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100314
Author(s):  
M.M. Javle ◽  
D.-Y. Oh ◽  
M. Ikeda ◽  
W.-P. Yong ◽  
K. Hsu ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Second Line ◽  
Tract Cancer ◽  
Randomized Phase Ii

scholarly journals Phase II study of evofosfamide (TH-302) monotherapy as a second-line treatment in advanced biliary tract cancer

2018 ◽  
Vol 29 ◽  
pp. viii259
Author(s):  
J.S. Yoon ◽  
K.-H. Lee ◽  
G.J. Cheon ◽  
Y.-J. Bang ◽  
D.-Y. Oh
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Line Treatment ◽  
Second Line ◽  
Tract Cancer

Imatinib Mesylate for Palliative Second-Line Treatment of Advanced Biliary Tract Cancer: A Bicentric Phase II Study

Onkologie ◽  
2011 ◽  
Vol 34 (8) ◽  
pp. 469-470 ◽  
Author(s):  
Annekathrin Roth ◽  
Eberhard Schleyer ◽  
Konrad Schoppmeyer ◽  
Regine Kluge ◽  
Christian Wittekind ◽  
...  
Keyword(s):  
Imatinib Mesylate ◽  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Line Treatment ◽  
Second Line ◽  
Tract Cancer

A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer

2013 ◽  
Vol 71 (4) ◽  
pp. 973-979 ◽  
Author(s):  
Takashi Sasaki ◽  
Hiroyuki Isayama ◽  
Yousuke Nakai ◽  
Yukiko Ito ◽  
Ichiro Yasuda ◽  
...  
Keyword(s):  
Combination Therapy ◽  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Tract Cancer ◽  
Randomized Phase Ii

Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine

2010 ◽  
Vol 30 (2) ◽  
pp. 708-713 ◽  
Author(s):  
Takashi Sasaki ◽  
Hiroyuki Isayama ◽  
Yousuke Nakai ◽  
Suguru Mizuno ◽  
Keisuke Yamamoto ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Tract Cancer ◽  
Multicenter Phase ◽  
Line Chemotherapy

Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancer

2017 ◽  
Vol 80 (6) ◽  
pp. 1189-1196 ◽  
Author(s):  
Satoshi Kobayashi ◽  
Makoto Ueno ◽  
Kazuya Sugimori ◽  
Chigusa Morizane ◽  
Yasushi Kojima ◽  
...  
Keyword(s):  
Dose Rate ◽  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Fixed Dose ◽  
Line Treatment ◽  
Second Line ◽  
Tract Cancer ◽  
Fixed Dose Rate
Sign in / Sign up

Export Citation Format

Share Document